Skip to content

IBEKLEVIC

Active Private limited companyfounded 2019active for 7 yearsRue des Petits Sarts 17, 6230 Pont-à-CellesKBO/BCE: BE 0721.624.174 #4 company by equity in Pont-à-Celles, Health and social work sector

Lifetime

7 annual accounts with figures on one time axis
peak of €380,887 in 2025
€380,887▲ 18.1%
peak of €236,181 in 2025
€236,181▲ 21.6%
peak of €621,831 in 2025
€621,831▲ 62.4%
€37,336▼ 65.7%
peak of 0.1 FTE in 2023
-not published
Board1 name since 2019
- 
Documentsfilings and deeds
04-07-202627 days before the deadline
2025micro format
Gross margin from €322,625 to €380,887Equity from €382,901 to €621,831Debts from €108,763 to €37,336Cash from €345,058 to €179,935

Key points

from the 2025 annual accounts

Equity

€621,831 ▲ 62.4%
€383,0002024€622,0002025

Equity rose in 2025 from €382,901 to €621,831.

Turnover

≈ €570,000 estimated

The accounts state no turnover.

Staff

1 employees on 31-12-2025
102023012025

In 2025, nobody joined and 1 employee left.

Liquidity

18.28 was 4.48 in 2024

Short-term debts fell from €108,763 to €35,836.

Filings

7 annual accounts 6 late
AprilJune31 JulyOctober202020222024

The 2019 accounts came in latest, 101 days after the end of the period.

Position in the sector

€236,181

Higher net result than 91% of companies in human health. Sector median €59,553 · 21,334 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as IBEKLEVIC has now. Each dot stands for 68 companies, two years later.

94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for IBEKLEVIC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

last known board
Manager, last mentioned in 2019
  • founderdeed of 11-03-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0721624174
Legal-form change · Resignations & appointments Legal-form conversion: from private limited company (pre-2019) to private limited company · Board composition: (director) · Gazette deed
Registered office moved from Gosselies to Viesville The registered office moved from Rue de l'Escasse 18/012 à 6041 Gosselies (Charleroi) to Rue des Petits Sarts 17 à 6230 Viesville · General meeting of 10-08-2020 · Gazette deed
First establishment Rue de l'Escasse 18, Charleroi
All 19 events

Comparable companies

same main activity, similar in size and age
Company
IBEKLEVIC Pont-à-Celles €659,167 €380,887 94.3% -
Dr. Agostoni Schilde €666,200 €388,918 2.8% -
DR. VIAENE ELS Moorslede €660,062 €362,720 51.4% -
DR. DEPUYDT ELINE - ANESTHESIE Kruisem €672,644 €398,365 25.4% -
Cabinet de radiologie GKZ Liège €673,309 €381,575 48.7% -
DR. TOM VAN DEN LANGENBERGH Kapellen €610,837 €381,796 24.9% -
MKA West-Limburg Heusden-Zolder €707,119 €392,237 16.0% 5.2

These companies have the same main activity as IBEKLEVIC: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €611,000 and €707,000, founded between 2018 and 2019.

Official details

Source: KBO
Status
Active since 27-02-2019Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.287.666.8066041 Charleroi, since 28-02-2019
Financial year end
31 December
Peppol
Reachable since 06-01-2026
Company details

Annual accounts 2025

€659,167▲ 34.1%
Employeeson 31-12-2025
1=
Filing
Filed on 04-07-2026, 27 days before the end of the filing period
Financials

Insights on IBEKLEVIC

IBEKLEVIC files the micro format. That format states no turnover. The gross margin rose from €93,741 in 2019 to €380,887 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about IBEKLEVIC

What is the company number of IBEKLEVIC?
The company number of IBEKLEVIC is 0721.624.174. The VAT number is the same number with BE in front: BE 0721.624.174.
Where is IBEKLEVIC based?
The registered office is at Rue des Petits Sarts 17, 6230 Pont-à-Celles.Company details
What does IBEKLEVIC do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of IBEKLEVIC?
IBEKLEVIC is a private limited company (BV).
When was IBEKLEVIC founded?
IBEKLEVIC was founded on 27-02-2019.
Is IBEKLEVIC still active?
Yes, IBEKLEVIC is an active enterprise in the KBO register.
How many employees does IBEKLEVIC have?
IBEKLEVIC had an average of 0.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of IBEKLEVIC?
The turnover in financial year 2025 is ≈ €570,000. This figure is estimated from the gross margin of €380,887 and 31 comparable companies (NACE 86220). It probably lies between €510,000 and €800,000. In financial year 2019 turnover was €201,394.
Is IBEKLEVIC profitable?
In financial year 2025, IBEKLEVIC made a profit of €236,181.
Where can I find the annual accounts of IBEKLEVIC?
IBEKLEVIC filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of IBEKLEVIC due?
IBEKLEVIC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.